Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7250297 Anticalins

Patent 7250297 was granted and assigned to Pieris AG on July, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 28 Aug, 2024

"update inverses"

edited on 28 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12071484 Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein

0

"update inverses"

edited on 28 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12071473 VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders

0

Edits on 21 Aug, 2024

"update inverses"

edited on 21 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12065478 HER2-targeting antigen binding molecules comprising 4-1BBL

0

"update inverses"

edited on 21 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12064463 Vista antagonist and methods of use

0

Edits on 14 Aug, 2024

"update inverses"

edited on 14 Aug, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12059476 Biodegradable biomimetic particles

0

Edits on 31 Jul, 2024

"update inverses"

edited on 31 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

0

"update inverses"

edited on 31 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

0

Edits on 24 Apr, 2024

"update inverses"

edited on 24 Apr, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11965025 Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules

0

Edits on 2 Mar, 2024

"update inverses"

edited on 2 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11912761 IL-1β neutralizing human monoclonal antibodies

0

Edits on 11 Oct, 2023

"update inverses"

edited on 11 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11780913 IL-1β neutralizing human monoclonal antibodies

Edits on 16 Sep, 2023

"Add patent inventor(s)"

edited on 16 Sep, 2023

Edits made to:

Infobox (+4 properties)

Infobox

Patent Inventor Names

Arne Skerre0

Frank Schmidt0

Gerald Beste0

Thomas Stibora0

Edits on 13 Sep, 2023

"update inverses"

edited on 13 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11752189 Vista antagonist and methods of use

Edits on 1 Sep, 2023

"Add patent abstract"

edited on 1 Sep, 2023

Edits made to:

Article (+427 characters)

Article

Patent abstract

The invention relates to the production of novel proteins exhibiting bonding activity for certain ligands, the so-called anticalins. To this end, the structure of peptides of the lipocalin family is modified by amino acid replacement in their natural ligand binding pocket using genetic engineering methods. A like immunoglobulin, the anticalin thus obtained can be used to identify or bond molecular structures.

Edits on 21 Jul, 2023

"Remove website redirecting to Patent Public Search front page"

edited on 21 Jul, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=072502970

Edits on 19 Jul, 2023

"update inverses"

edited on 19 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11702471 IL-1β neutralizing human monoclonal antibodies

0

Edits on 14 Jun, 2023

"update inverses"

edited on 14 Jun, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11674959 Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors

0

Edits on 17 May, 2023

"Remove leading 0 from patent number"

edited on 17 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 07250297 Anticalins US Patent 7250297 Anticalins

Infobox

Patent Number

072502970

Patent Number

72502970

Edits on 24 Sep, 2022

"Entity importer update"

edited on 24 Sep, 2022

Infobox

Is a

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

072502970

Date of Patent

July 31, 2007

0

Patent Application Number

095094440

Date Filed

September 25, 1998

0

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=072502970

Patent Primary Examiner

Elizabeth Kemmerer

0

Edits on 15 Jun, 2022

"Entity importer update"

edited on 15 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=07250297

Edits on 22 Nov, 2021

"Created via: Entity Importer"

created this topic on 22 Nov, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 07250297 Anticalins

Infobox

Is a

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

07250297

Date of patent

July 31, 2007

Patent application number

09509444

Date Filed

September 25, 1998

Patent primary examiner

Elizabeth Kemmerer

Find more entities like US Patent 7250297 Anticalins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool